Home
Regenxbio RGNX spent $91K on lobbying in Q4 2023 · Health Issues, Trade and 3 more issues
Trade details
- Type
- Lobbying report
- Amount
- $91,000
- Quarter
- Q4 2023
- Stock
- Regenxbio RGNX
- Client
- Regenxbio
- Reported
- 24/01/22
Down 3.2% from last quarter
What else happened in Regenxbio around then
Filed or reported within 30 days of the trade day · 23/12/01~24/01/30Regenxbio's other lobbying reports
- Regenxbio
LobbyingRegenxbio
LobbyingRegenxbio
RGNX
$60K
$60K
Reported 07/20
for Q2
- Regenxbio
LobbyingRegenxbio
LobbyingRegenxbio
RGNX
$60K
$60K
Reported 07/17
for Q2
- Regenxbio
LobbyingRegenxbio
LobbyingRegenxbio
RGNX
$60K
$60K
Reported 07/05
for Q2
- Regenxbio
LobbyingRegenxbio
LobbyingRegenxbio
RGNX
$60K
$60K
Reported 04/20
for Q1
- Regenxbio
LobbyingRegenxbio
LobbyingRegenxbio
RGNX
$60K
$60K
Reported 04/17
for Q1